We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Cefepime pharmacokinetics in critically ill children and young adults undergoing continuous kidney replacement therapy.
- Authors
Pavia, Kathryn; Hambrick, H Rhodes; Paice, Kelli; Tang, Peter; Punt, Nieko; Kaplan, Jennifer; Goldstein, Stuart L; Vinks, Alexander A; Mizuno, Tomoyuki; Girdwood, Sonya Tang
- Abstract
Objectives Cefepime is an antibiotic commonly used to treat sepsis and is cleared by renal excretion. Cefepime dosing requires adjustment in patients with decreased kidney function and in those receiving continuous kidney replacement therapy (CKRT). We aimed to characterize cefepime PK in a diverse cohort of critically ill paediatric patients on CKRT. Methods Patients were identified from an ongoing pharmacokinetic/pharmacodynamic (PK/PD) study of beta-lactam antibiotics, and were included if they had received at least two cefepime doses in the ICU and were on CKRT for at least 24 h. PK parameters were estimated using MwPharm++ with Bayesian estimation and a paediatric population PK model. Target attainment was assessed as time of free cefepime concentrations above minimum inhibitory concentration (f T > 1× or 4 × MIC). Results Seven patients were included in the study (ages 2 to 20 years). CKRT indications included liver failure (n = 1), renal failure (n = 4) and fluid overload (n = 2). Total effluent flow rates ranged from 1833 to 3115 (mean 2603) mL/1.73 m2/h, while clearance was 2.11–3.70 (mean 3.0) L/h/70 kg. Effluent flows were lower, but clearance and f T > MIC were similar to paediatric data published previously. Using Pseudomonas aeruginosa MIC breakpoints, all patients had 100% of dosing interval above MIC, but only one had 100% of dosing interval above 4× MIC. Conclusions Since most patients failed to attain stringent targets of 100% f T > 4× MIC, model-informed precision dosing may benefit such patients.
- Subjects
CRITICALLY ill children; RENAL replacement therapy; YOUNG adults; CHILD patients; CEFEPIME; LACTAMS
- Publication
Journal of Antimicrobial Chemotherapy (JAC), 2023, Vol 78, Issue 9, p2140
- ISSN
0305-7453
- Publication type
Article
- DOI
10.1093/jac/dkad192